Osaic Holdings
NKTR icon

Osaic Holdings’s Nektar Therapeutics NKTR Stock Holding History

Osaic Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Sell
4,393
-995
-18% -$56.7K ﹤0.01% 3779
2025
Q4 		$228K Sell
5,388
-38
-0.7% -$2.13K ﹤0.01% 4036
2025
Q3 		$282K Buy
5,426
+38
+0.7% +$1.26K ﹤0.01% 3927
2025
Q2 		$139K Sell
5,388
-33
-0.6% -$371 ﹤0.01% 4236
2025
Q1 		$55.3K Buy
5,421
+2,683
+98% +$35.1K ﹤0.01% 4640
2024
Q4 		$38.2K Sell
2,738
-66
-2% -$1.16K ﹤0.01% 4895
2024
Q3 		$54.7K Buy
2,804
+222
+9% +$4.23K ﹤0.01% 4675
2024
Q2 		$48K Sell
2,582
-587
-19% -$12.4K ﹤0.01% 4710
2024
Q1 		$44.3K Buy
3,169
+917
+41% +$9.6K ﹤0.01% 4833
2023
Q4 		$19.1K Sell
2,252
-711
-24% -$5.38K ﹤0.01% 5519
2023
Q3 		$26.5K Sell
2,963
-201
-6% -$1.94K ﹤0.01% 5398
2023
Q2 		$27.2K Buy
3,164
+266
+9% +$2.84K ﹤0.01% 5358
2023
Q1 		$31.1K Buy
2,898
+143
+5% +$4.33K ﹤0.01% 5294
2022
Q4 		$92.5K Sell
2,755
-296
-10% -$14.3K ﹤0.01% 4502
2022
Q3 		$147K Buy
3,051
+13
+0.4% +$773 ﹤0.01% 4031
2022
Q2 		$174K Sell
3,038
-59
-2% -$3.72K ﹤0.01% 3931
2022
Q1 		$3.46M Buy
3,097
+871
+39% +$129K 0.01% 1477
2021
Q4 		$452K Buy
2,226
+380
+21% +$82.4K ﹤0.01% 3164
2021
Q3 		$498K Sell
1,846
-885
-32% -$213K ﹤0.01% 3035
2021
Q2 		$702K Buy
2,731
+460
+20% +$127K ﹤0.01% 2666
2021
Q1 		$681K Sell
2,271
-125
-5% -$38.9K ﹤0.01% 2560
2020
Q4 		$611K Sell
2,396
-185
-7% -$47.8K ﹤0.01% 2460
2020
Q3 		$645K Buy
2,581
+269
+12% +$84.6K ﹤0.01% 2202
2020
Q2 		$803K Sell
2,312
-768
-25% -$240K ﹤0.01% 1921
2020
Q1 		$809K Buy
+3,080
New +$953K ﹤0.01% 1693

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Osaic Holdings's NKTR Position: Q1 2026 in Review

Osaic Holdings reduced its Nektar Therapeutics (NKTR) stake by 18% in Q1 2026, selling an estimated $56.7K and leaving 4,393 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #3779.

Osaic Holdings first reported a position in NKTR in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.46M in Q1 2022. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Osaic Holdings held 4,393 shares of Nektar Therapeutics worth $316K as of Q1 2026.
  • Osaic Holdings sold 995 Nektar Therapeutics shares in Q1 2026, an estimated $56.7K.
  • Nektar Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3779 holding.
  • Osaic Holdings first reported a position in Nektar Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Nektar Therapeutics position peaked at $3.46M in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.